miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy

miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy

The therapeutic application of microRNA(s) in the field of cancer has generated significant attention in research. Previous studies have shown that miR-205 negatively regulates prostate cancer cell proliferation, metastasis, and drug resistance. However, the delivery of miR-205 is an unmet clinical...

Full description

Bibliographic Details
Main Authors: Prashanth K. B. Nagesh, Pallabita Chowdhury, Elham Hatami, Vijaya K. N. Boya, Vivek K. Kashyap, Sheema Khan, Bilal B. Hafeez, Subhash C. Chauhan, Meena Jaggi, Murali M. Yallapu
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:Cancers
Subjects:
miR-205
docetaxel
prostate cancer
chemosensitivity and EMT
Online Access:http://www.mdpi.com/2072-6694/10/9/289

Internet

http://www.mdpi.com/2072-6694/10/9/289

Similar Items